摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-((1-(2-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-oxoethyl)-5,6-dimethyl-1H-benzo[d]imidazol-2-yl)amino)propyl hept-6-ynoate | 1135306-30-7

中文名称
——
中文别名
——
英文名称
3-((1-(2-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-oxoethyl)-5,6-dimethyl-1H-benzo[d]imidazol-2-yl)amino)propyl hept-6-ynoate
英文别名
3-[[1-[2-(3,5-Ditert-butyl-4-hydroxyphenyl)-2-oxoethyl]-5,6-dimethylbenzimidazol-2-yl]amino]propyl hept-6-ynoate
3-((1-(2-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-oxoethyl)-5,6-dimethyl-1H-benzo[d]imidazol-2-yl)amino)propyl hept-6-ynoate化学式
CAS
1135306-30-7
化学式
C35H47N3O4
mdl
——
分子量
573.776
InChiKey
AOAVJAQOVQJVEB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    685.3±65.0 °C(predicted)
  • 密度:
    1.08±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    8.6
  • 重原子数:
    42
  • 可旋转键数:
    15
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.51
  • 拓扑面积:
    93.4
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    6-庚炔酸1-[3,5-二(1,1-二甲基乙基)-4-羟基苯基]-2-[2-[(3-羟基丙基)氨基]-5,6-二甲基-1H-苯并咪唑-1-基]-乙酮4-二甲氨基吡啶盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 二氯甲烷 为溶剂, 反应 24.17h, 以73%的产率得到3-((1-(2-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-oxoethyl)-5,6-dimethyl-1H-benzo[d]imidazol-2-yl)amino)propyl hept-6-ynoate
    参考文献:
    名称:
    Inhibition of Protein Kinase C-Driven Nuclear Factor-κB Activation: Synthesis, Structure−Activity Relationship, and Pharmacological Profiling of Pathway Specific Benzimidazole Probe Molecules
    摘要:
    A unique series of biologically active chemical probes that selectively inhibit NF-kappa B activation induced by protein kinase C (PKC) pathway activators have been identified through a cell-based phenotypic reporter gene assay. These 2-aminobenzimidazoles represent initial chemical tools to be used in gaining further understanding on the cellular mechanisms driven by B and T cell antigen receptors. Starting from the founding member of this chemical series 1a (notated in PubChem as CID-2858522), we report the chemical synthesis, SAR studies, and pharmacological profiling of this pathway-selective inhibitor of NF-kappa B activation.
    DOI:
    10.1021/jm1000248
点击查看最新优质反应信息

文献信息

  • Inhibition of Protein Kinase C-Driven Nuclear Factor-κB Activation: Synthesis, Structure−Activity Relationship, and Pharmacological Profiling of Pathway Specific Benzimidazole Probe Molecules
    作者:Satyamaheshwar Peddibhotla、Ranxin Shi、Pasha Khan、Layton H. Smith、Arianna Mangravita-Novo、Michael Vicchiarelli、Ying Su、Karl J. Okolotowicz、John R. Cashman、John C. Reed、Gregory P. Roth
    DOI:10.1021/jm1000248
    日期:2010.6.24
    A unique series of biologically active chemical probes that selectively inhibit NF-kappa B activation induced by protein kinase C (PKC) pathway activators have been identified through a cell-based phenotypic reporter gene assay. These 2-aminobenzimidazoles represent initial chemical tools to be used in gaining further understanding on the cellular mechanisms driven by B and T cell antigen receptors. Starting from the founding member of this chemical series 1a (notated in PubChem as CID-2858522), we report the chemical synthesis, SAR studies, and pharmacological profiling of this pathway-selective inhibitor of NF-kappa B activation.
查看更多